Remove CEO Remove Conflict of Interest Remove Development Remove Finance
article thumbnail

The “Maximize Profits” Trap in Decision Making

Harvard Business Review

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. From a historical perspective, the idea that managers in organizations have a single, dominant duty — to achieve or maximize economic returns — is a striking development. How should you make this decision?

ROI 8
article thumbnail

At Olympus and Goldman Sachs, Two Very Different Whistleblowers

Harvard Business Review

The first whistleblower — using facts — is former Olympus CEO Michael Woodford , who uncovered a huge accounting fraud at the company. In 2011, Woodford was asked to lead the Japanese maker of optical equipment, first as president (in April) then as CEO (in September). He then went public.